FAQs and Research Articles

At Myocarditis Foundation, we’re committed to addressing the dire need for more information about myocarditis. An inflammatory response attacking the heart, myocarditis can lead to serious complications, from cardiac dysfunction to heart failure. Find the answers you need about myocarditis with our carefully curated frequently asked questions (FAQs) and relevant research articles from trusted sources.

Myocarditis Foundation routinely scours the world of medical research to bring you information on the latest developments concerning myocarditis, pericarditis, and more. Consult the following resources to learn more:

Myocarditis and Cardiomyopathy

• Gonadectomy of Male BALB/c Mice Increase Tim-3⁺Alternatively Activated M2 Macrophages, Tim-3⁺T Cells, Th2 Cells and Treg in the Heart During Acute Coxsackievirus-Induced Myocarditis
• The Regulation of Viral Myocarditis in Mice: Different Roles for TLR3 versus TRIF in Progression to Chronic Disease
• Incidence, Causes, and Outcomes of Dilated Cardiomyopathy in Children
• Ventricular Remodeling and Survival Are More Favorable for Myocarditis than for Idiopathic Dilated Cardiomyopathy in Childhood: An Outcomes Study from the Pediatric Cardiomyopathy Registry
• The Incidence of Pediatric Cardiomyopathy in Two Regions of the United States
• Long-Term Risk of Recurrence, Morbidity, and Mortality in Giant Cell Myocarditis
• Recognition and Initial Management of Fulminant Myocarditis
• Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment
• Myoglobin for Detection of High-Risk Patients with Acute Myocarditis
• Management of Patients with Giant Cell Myocarditis
• Immunoglobulin Biomarker of Heart Failure with Myocarditis
• Myocardial Involvement in Coronavirus Disease 19
• Diagnosis and treatment of HCV heart diseases
• Endomyocardial Biopsy
• Viral Myocarditis from Animal Models to Human Disease
• Cardiovascular Disease Manifestations of Hepatitis C Virus
• Myocarditis and Autoimmunity
• Care & Outcomes of Critically-ill Children With Diagnosed Myocarditis
• Rationale and design of the ARAMIS trial: Anakinra versus placebo, a double blind randomized controlled trial for the treatment of acute myocarditis

Myocarditis Foundation is staying abreast of all developments pertaining to COVID-19 and its link to myocarditis and other forms of heart disease. Heart Failure Society of America (HFSA) has created an online resource center for heart failure patients, caregivers, and care providers. It also advises these individuals to adhere to all recommendations from the Centers for Disease Control and Prevention (CDC).

In addition, Myocarditis Foundation offers the following resources regarding COVID-19:

• Leslie Cooper, Medical Director for Myocarditis Foundation, Speaks on How COVID-19 Affects the Heart
• Mayo Clinic News Network Article on COVID-19’s Effects on the Heart
• Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome
• American College of Cardiology Clinical Bulletin Focuses on Cardiac Implications of Coronavirus (COVID-19)
• FDA Coronavirus Disease 2019
• Department of Labor Workplace Safety and Leave Information

If you’d like to learn more about myocarditis and heart disease, browse our myocarditis research photos and blog today. If you have additional questions, send an email to [email protected] or contact us online.

Want to learn more? Browse myocarditis research photos!